American Brivision (ABVC) 10-K Annual Report December 2009

The following information was filed by American Brivision (ABVC) on Tuesday, April 28, 2009 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

Please wait while we load the requested 10-K report or click the link below:

https://last10k.com/sec-filings/report/1173313/000117331309000134/tenk2009.htm

View differences made from one year to another to evaluate American Brivision's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ) — *Sample 10-K Year-over-Year (YoY) Comparison*

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were ~~removed~~ , added and changed by American Brivision.

Continue

Assess how American Brivision's management team is paid from their Annual Proxy

American Brivision's Definitive Proxy Statement (Form DEF 14A) filed after their 2009 10-K Annual Report includes:

Voting Procedures
Board Members
Executive Team
Salaries, Bonuses, Perks
Peers / Competitors

Continue

Material Contracts, Statements, Certifications & more

American Brivision provided additional information to their SEC Filing as exhibits

Exhibit 23.3: Uhy Llp Consent For S-8 Incorporation

Exhibit 31.1: Ceo Certification

Exhibit 31.2: Cfo Certification

Exhibit 32.1: Joint Certification

Ticker: ABVC
CIK: 1173313
Form Type: 10-K Annual Report
Accession Number: 0001173313-09-000134
Submitted to the SEC: Tue Dec 22 2009 5:06:09 PM EST
Accepted by the SEC: Tue Dec 22 2009
Period: Tuesday, December 22, 2009
Industry: Pharmaceutical Preparations